HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
It was in 1934 that German chemist Karl Meyer and his British student John Palmer first isolated Hyaluronic Acid from the human body.
This year marks the 90th anniversary of the discovery of this molecule, which is used today in a large number of leading therapeutic areas and whose chemical specificities still conceal many discoveries for years to come.
To mark the occasion, HTL Biotechnology is committed to celebrating this anniversary throughout 2024. On the agenda : events and presentations on Hyaluronic Acid will guide you into the world of this fascinating molecule.
For the more curious among you, stay tuned by subscribing to the hashtag #90YearsofHAwithHTL ! 2024 is set to be a year full of learning and discovery !
The European Society of Cataract and Refractive Surgeons (ESCRS) is a unique opportunity each year to connect with our clients and partners while gaining insights into the key trends shaping the future of ophthalmology.
We’re pleased to share our second CSR report, highlighting the actions and commitments we carried out throughout 2024.
A Global Scientific Gathering Dedicated to Hyaluronic Acid Innovation.